Category: Pharmaceutical company
Quick infos Headquarters: Massachusetts, United States Trade prices Volume: Market Cap: 2.56B Prev closed: 81.6 Open: 82.12 High: 87.89 Low: 80.59 52 week low: 14.01 52 week high: 96.45 Dividends: No Dividends Next ER: November 4, 2021
About the Company Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPRâCas9 gene editing technology. The company went public on 2 Feb 2016.
Earnings History Date EPS / Forecast Revenue / Forecast November 10, 2021 August 4, 2021 -0.81 / -0.8235379K / 6.03MBeat! May 5, 2021 -0.86 / -0.74386.5M / 5.83MBeat! February 25, 2021 -1 / -0.7611.42M / 5.64MBeat! November 5, 2020 0.12 / -0.62662.84M / 6.36MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Oct 8, 2021 35.74 38.47 38.47
35.26
874.49K -8.43% Oct 7, 2021 39.03 37.91 40.18
37.48
1.78M 3.97% Oct 6, 2021 37.54 37.50 39.14
36.90
1.41M -1.8% Oct 5, 2021 38.23 37.63 38.92
37.33
1.43M 2.52% Oct 4, 2021 37.29 39.44 39.64
37.11
2.00M -6.56% Oct 1, 2021 39.91 41.06 41.12
38.78
2.20M -2.85% Sep 30, 2021 41.08 42.15 42.17
39.61
4.72M -3.34% Sep 29, 2021 42.50 49.00 50.20
41.02
9.82M -18.97% Sep 28, 2021 52.45 55.31 55.75
52.01
2.80M -9.32% Sep 27, 2021 57.84 58.69 59.43
56.60
1.66M -1.48% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Editas Medicine Unveils Preclinical Data From New Gene Editing Technology finance.yahoo.com Sep 10, 2021 6:11 am
3 Red-Hot Healthcare Stocks to Buy in September fool.com Sep 9, 2021 12:37 pm
Initial Clinical Data from Editas Medicines BRILLIANCE Clinical Trial of EDIT-101 for LCA10 to be Presented at the International Symposium on Retinal Degeneration in September finance.yahoo.com Sep 7, 2021 4:00 pm
Is Editas Medicine (NASDAQ:EDIT) A Risky Investment? finance.yahoo.com Sep 1, 2021 8:15 am
Editas (EDIT) Up More Than 70% in Past 3 Months: Here's Why finance.yahoo.com Aug 17, 2021 10:21 am
Editas Medicine Announces Pricing of Offering of Common Stock finance.yahoo.com Aug 9, 2021 10:30 pm
Why Editas Medicine Beat the Market on Monday fool.com Aug 9, 2021 6:05 pm Why Editas Medicine Stock Sank Today fool.com Aug 9, 2021 4:08 pm What Really Mattered With Editas Medicine's Q1 Update fool.com Aug 9, 2021 2:46 pm Why Editas Medicine Stock Is Getting Crushed Today fool.com Aug 9, 2021 2:39 pm
10 Best Up and Coming Stocks to Invest In finance.yahoo.com Aug 9, 2021 9:35 am
Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates finance.yahoo.com Aug 9, 2021 8:20 am Editas Medicine Falls as Goldman Sachs Initiates the Stock at Sell thestreet.com Aug 9, 2021 7:05 am
Editas Medicine (EDIT) Reports Q2 Loss, Misses Revenue Estimates finance.yahoo.com Aug 9, 2021 8:15 am
Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update finance.yahoo.com Aug 9, 2021 7:00 am
Editas Medicine Names Mark S. Shearman, Ph.D., as Chief Scientific Officer finance.yahoo.com Aug 9, 2021 6:59 am
Intellia Soars On Positive Results In Gene-Editing Treatment finance.yahoo.com Aug 9, 2021 5:34 am Nasdaq Stays Flat as Workhorse Drives Higher, Editas Sinks fool.com Aug 5, 2021 3:31 pm
Goldman Sachs Just Put Editas Stock on Sale Buy the Dip finance.yahoo.com Aug 5, 2021 2:05 pm
Editas (EDIT) Q2 Earnings Beat Estimates, Revenues Fall Y/Y finance.yahoo.com Aug 5, 2021 12:43 pm This company doesn't provide a dividend.
Key Persons Talk about Editas below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
